Thrivent Financial for Lutherans Trims Stake in Axcelis Technologies, Inc. (NASDAQ:ACLS)

Thrivent Financial for Lutherans lowered its position in Axcelis Technologies, Inc. (NASDAQ:ACLS) by 3.8% in the 3rd quarter, Holdings Channel reports. The fund owned 28,240 shares of the semiconductor company’s stock after selling 1,119 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Axcelis Technologies were worth $2,961,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. Signaturefd LLC raised its holdings in Axcelis Technologies by 348.9% in the second quarter. Signaturefd LLC now owns 211 shares of the semiconductor company’s stock worth $30,000 after purchasing an additional 164 shares in the last quarter. Blue Trust Inc. increased its stake in shares of Axcelis Technologies by 223.8% in the 2nd quarter. Blue Trust Inc. now owns 272 shares of the semiconductor company’s stock worth $39,000 after acquiring an additional 188 shares in the last quarter. Ashton Thomas Private Wealth LLC purchased a new position in Axcelis Technologies during the 2nd quarter valued at about $39,000. Isthmus Partners LLC boosted its stake in Axcelis Technologies by 87.3% during the second quarter. Isthmus Partners LLC now owns 33,270 shares of the semiconductor company’s stock worth $47,000 after acquiring an additional 15,507 shares in the last quarter. Finally, Meeder Asset Management Inc. purchased a new stake in Axcelis Technologies in the second quarter worth about $69,000. 89.98% of the stock is currently owned by institutional investors.

Axcelis Technologies Stock Performance

ACLS stock opened at $74.45 on Wednesday. The stock’s 50 day simple moving average is $91.06 and its 200 day simple moving average is $110.67. The company has a current ratio of 4.45, a quick ratio of 3.29 and a debt-to-equity ratio of 0.04. Axcelis Technologies, Inc. has a 12-month low of $69.35 and a 12-month high of $158.61. The stock has a market capitalization of $2.42 billion, a PE ratio of 11.01, a price-to-earnings-growth ratio of 2.34 and a beta of 1.60.

Analyst Ratings Changes

A number of brokerages have recently commented on ACLS. B. Riley dropped their price target on Axcelis Technologies from $190.00 to $165.00 and set a “buy” rating on the stock in a research report on Friday, August 2nd. Needham & Company LLC reissued a “hold” rating on shares of Axcelis Technologies in a report on Friday, November 8th. Finally, Benchmark downgraded Axcelis Technologies from a “buy” rating to a “hold” rating in a report on Friday, November 8th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, Axcelis Technologies currently has an average rating of “Moderate Buy” and an average price target of $167.33.

Axcelis Technologies Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.